Sponsor
1 Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma Annals of Oncology, May 14, 2013
2 Mass Distribution of Azithromycin for Trachoma Control Is Associated With Increased Risk of Azithromycin-Resistant Streptococcus pneumoniae Carriage in Young Children 6 Months After Treatment Clinical Infectious Diseases, May 9, 2013
3 Significant efficacies of neoadjuvant and adjuvant chemotherapy for nasopharyngeal carcinoma by meta-analysis of published literature-based randomized, controlled trials Annals of Oncology, May 8, 2013 Evidence Based Medicine
4 The role of plasma Epstein-Barr virus DNA in the management of recurrent nasopharyngeal carcinoma The Laryngoscope, May 21, 2013 Review Article
5 Influence of gender and age on the survival of patients with nasopharyngeal carcinoma BMC Cancer, May 7, 2013
6 Clinical validation and applications for CT-based atlas for contouring the lower cranial nerves for head and neck cancer radiation therapy Oral Oncology , April 30, 2013
7 JAK inhibitor tofacitinib for treating rheumatoid arthritis: from basic to clinical Modern Rheumatology, May 14, 2013
8 Consumption of fruit, vegetables, and other food groups and the risk of nasopharyngeal carcinoma Cancer Causes and Control, May 8, 2013
9 PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies Clinical Cancer Research, May 16, 2013
10 Radiation induced squamous cell carcinoma of the nasopharynx after radiotherapy for nasopharyngeal carcinoma Head & Neck, May 2, 2013
Sponsor
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor